Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

PubWeight™: 3.04‹?› | Rank: Top 1%

🔗 View Article (PMID 1514781)

Published in Ann Neurol on June 01, 1992

Authors

A Chiba1, S Kusunoki, T Shimizu, I Kanazawa

Author Affiliations

1: Department of Neurology, School of Medicine, University of Tokyo, Japan.

Articles citing this

Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev (1998) 4.39

Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry (2001) 3.05

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A (2004) 2.16

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74

Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev (2015) 1.73

Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol (2008) 1.57

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry (1993) 1.45

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest (1999) 1.42

Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev (2014) 1.32

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review. Glycobiology (2009) 1.19

Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (2006) 1.12

Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside. J Neurosci Res (2006) 0.98

Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. J Clin Microbiol (2005) 0.98

Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infect Immun (1997) 0.95

Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (2001) 0.95

Prevalence of anti-ganglioside antibodies and their clinical correlates with guillain-barré syndrome in Korea: a nationwide multicenter study. J Clin Neurol (2014) 0.92

Anti-GT1a IgG in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (2002) 0.92

Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry (1996) 0.92

GQ1b-seronegative Fisher syndrome: clinical features and new serological markers. J Neurol (2012) 0.91

Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey. Proc Jpn Acad Ser B Phys Biol Sci (2012) 0.90

Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry (1994) 0.90

Acute bilateral ophthalmoparesis with pupilary areflexical mydriasis in miller-fisher syndrome treated with intravenous immunoglobulin. J Ophthalmol (2010) 0.90

Bickerstaff's brainstem encephalitis associated with cytomegalovirus infection. J Neurol Neurosurg Psychiatry (1995) 0.89

Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias. Cerebellum (2016) 0.88

Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry (1993) 0.85

Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry (1994) 0.85

Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits. Infect Immun (2002) 0.84

Miller Fisher-Guillain-Barré overlap syndrome with enhancing lesions in the spinocerebellar tracts. J Neurol Neurosurg Psychiatry (1995) 0.84

Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome. J Neurol (2015) 0.83

Optic neuritis in anti-GQ1b positive recurrent Miller Fisher syndrome. Br J Ophthalmol (2003) 0.83

Unilateral external ophthalmoplegia in Miller Fisher syndrome: case report. BMC Ophthalmol (2007) 0.80

Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin. Nat Rev Neurol (2015) 0.79

Ganglioside complexes as targets for antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry (2006) 0.79

Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis. Mult Scler Int (2013) 0.78

Role of anti-GQ1B antibody in differential diagnosis of acute ophthalmoparesis. Neuropsychiatr Dis Treat (2010) 0.77

Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection. Infect Immun (1999) 0.77

Miller Fisher Syndrome: A Case Report Highlighting Heterogeneity of Clinical Features and Focused Differential Diagnosis. Hawaii J Med Public Health (2016) 0.76

Guillain-Barré syndrome: a century of progress. Nat Rev Neurol (2016) 0.76

Late Presentation of Ataxia, Areflexia, and Electrophysiological Abnormalities as Part of Miller Fisher Syndrome: Case Report. Neuroophthalmology (2016) 0.75

A Case of Miller Fisher Syndrome and Literature Review. Cureus (2017) 0.75

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis. PLoS One (2013) 0.75

A case of Miller Fisher syndrome during preoperative chemotherapy for breast cancer. Int J Clin Exp Med (2015) 0.75

Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis. J Peripher Nerv Syst (2013) 0.75

Unilateral Abducens Nerve Palsy as an Early Feature of Multiple Mononeuropathy Associated with Anti-GQ1b Antibody. Case Rep Neurol (2011) 0.75

Chronic sensory ataxic neuropathy and ophthalmoplegia with oculomotor nerve hypertrophy associated with IgM antibodies against gangliosides containing disialosyl groups. J Neurol Neurosurg Psychiatry (1997) 0.75

A Case of Miller Fisher Syndrome, Thromboembolic Disease, and Angioedema: Association or Coincidence? Am J Case Rep (2017) 0.75

Pupillary Involvement in Miller Fisher Syndrome. Neuroophthalmology (2013) 0.75

Ataxia, ophthalmoplegia, and areflexia: what would you think? Case Rep Neurol Med (2012) 0.75

Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause. Br J Ophthalmol (1998) 0.75

An Overlapping Case of Miller Fisher Syndrome, Bickerstaff's Encephalitis, and the ASMAN Variant of Guillain-Barre Syndrome. Case Rep Neurol Med (2016) 0.75

Bilateral oculomotor synkinesis following Miller Fisher syndrome. Int Ophthalmol (2012) 0.75

Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis. Front Immunol (2017) 0.75

Articles by these authors

A 300 kilobase interval genetic map of rice including 883 expressed sequences. Nat Genet (1994) 5.08

Clinical Studies on Behçet's Syndrome. Ann Rheum Dis (1963) 4.61

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature (1997) 4.27

Behçet disease (Behçet syndrome). Semin Arthritis Rheum (1979) 3.88

An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86

Studies on protein binding of cefazolin and other antibiotics. Jpn J Antibiot (1974) 3.59

Chromospheric alfvenic waves strong enough to power the solar wind. Science (2007) 3.58

IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology (2010) 3.34

Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology (1993) 3.31

MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity (1996) 3.20

Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12

Role of cytosolic phospholipase A2 in allergic response and parturition. Nature (1997) 2.88

Indoleamine 2,3-dioxygenase. Purification and some properties. J Biol Chem (1978) 2.78

Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat Immunol (2000) 2.67

Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J (2000) 2.49

The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt fraction during one-lung ventilation. Anesth Analg (1998) 2.38

Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem (1997) 2.38

Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjögren's syndrome. IV immunoglobulin. Neurology (2003) 2.37

A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med (2000) 2.30

SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet (2001) 2.30

Position of immobilization after dislocation of the glenohumeral joint. A study with use of magnetic resonance imaging. J Bone Joint Surg Am (2001) 2.24

Impact of single-port cholecystectomy on postoperative pain. Br J Surg (2011) 2.14

New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology (2005) 2.14

HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet (1997) 2.09

Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD). J Physiol (2001) 2.08

Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci U S A (1984) 2.05

Preferential activation of different I waves by transcranial magnetic stimulation with a figure-of-eight-shaped coil. Exp Brain Res (1997) 2.03

Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res (2000) 2.03

Keratosis follicularis squamosa (Dohi): a follicular keratotic disorder well known in Japan. Br J Dermatol (2001) 2.01

Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry (2004) 2.00

Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98

Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med (1998) 1.98

Paired-pulse magnetic stimulation of the human motor cortex: differences among I waves. J Physiol (1998) 1.96

Early gastric cancer. Endoscopic diagnosis of depth of invasion. Dig Dis Sci (1990) 1.94

Adherence of Bordetella bronchiseptica to swine nasal epithelial cells and its possible role in virulence. Res Vet Sci (1979) 1.93

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet (2000) 1.92

Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue. J Biol Chem (1998) 1.86

Protective role of ATP-sensitive potassium channels in hypoxia-induced generalized seizure. Science (2001) 1.84

Immunological studies on Behçet's syndrome. Ann Rheum Dis (1965) 1.82

Post mortem changes and regional distribution of substance P in the rat and mouse nervous system. Brain Res (1976) 1.82

The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens. J Bacteriol (1996) 1.82

Partial purification and characterization of UDPG:t-cinnamate glucosyltransferase in the root of sweet potato, Ipomoea batatas Lam. J Biochem (1984) 1.82

Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes (2001) 1.82

Gliding mutants of Mycoplasma mobile: relationships between motility and cell morphology, cell adhesion and microcolony formation. Microbiology (2000) 1.80

Successful and safe use of 2 min cold atmospheric argon plasma in chronic wounds: results of a randomized controlled trial. Br J Dermatol (2012) 1.78

Crystal structure of an IRF-DNA complex reveals novel DNA recognition and cooperative binding to a tandem repeat of core sequences. EMBO J (1999) 1.77

Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res (1997) 1.76

Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology (2000) 1.76

Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel. Nature (1989) 1.74

Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill (2015) 1.73

Atrophic rhinitis produced by intranasal inoculation of Bordetella bronchiseptica in hysterectomy produced colostrum-deprived pigs. Cornell Vet (1971) 1.71

Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp Eye Res (1986) 1.70

Leukotriene A4 hydrolase in human leukocytes. Purification and properties. J Biol Chem (1984) 1.70

Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death. J Membr Biol (2006) 1.68

Architectures of class-defining and specific domains of glutamyl-tRNA synthetase. Science (1995) 1.68

Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis. Ann Neurol (1999) 1.67

Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res (1994) 1.66

Splenic artery embolization before laparoscopic splenectomy in children. Surg Endosc (2005) 1.65

The distribution of substance P immunoreactive fibers in the rat central nervous system. J Comp Neurol (1978) 1.63

Structural basis for the diversity of DNA recognition by bZIP transcription factors. Nat Struct Biol (2000) 1.63

Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant (2012) 1.61

A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61

Magnetic stimulation over the cerebellum in humans. Ann Neurol (1995) 1.61

Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy (2000) 1.59

The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr (1997) 1.58

Analysis of a suppressor mutation ssb (kinC) of sur0B20 (spo0A) mutation in Bacillus subtilis reveals that kinC encodes a histidine protein kinase. J Bacteriol (1995) 1.56

Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan. Biochim Biophys Acta (1998) 1.55

On the X-Ray Absorption Wave-Lengths of Lead Isotopes. Proc Natl Acad Sci U S A (1919) 1.53

Extensible and less-extensible domains of connectin filaments in stretched vertebrate skeletal muscle sarcomeres as detected by immunofluorescence and immunoelectron microscopy using monoclonal antibodies. J Biochem (1988) 1.53

Endothelin: a novel peptide in the posterior pituitary system. Science (1990) 1.51

Teratoma in a feline unilateral cryptorchid testis. Vet Pathol (2001) 1.51

Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology (2000) 1.51

Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome. Neurology (2004) 1.50

CSF hypocretin levels in Guillain-Barré syndrome and other inflammatory neuropathies. Neurology (2003) 1.50

Bacterial translocation and tumor necrosis factor-alpha gene expression in experimental hemorrhagic shock. Crit Care Med (2000) 1.49

Endovascular therapy of 500 small asymptomatic unruptured intracranial aneurysms. AJNR Am J Neuroradiol (2012) 1.49

A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients. Br J Dermatol (2010) 1.45

On the nature of the 5-lipoxygenase reaction in human leukocytes: characterization of a membrane-associated stimulatory factor. Proc Natl Acad Sci U S A (1985) 1.45

Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function. Cancer Res (1997) 1.44

Screening for imprinted genes by allelic message display: identification of a paternally expressed gene impact on mouse chromosome 18. Proc Natl Acad Sci U S A (1997) 1.43

Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun (1997) 1.43

Real-time tumour-tracking radiotherapy. Lancet (1999) 1.42

Insights into multistep phosphorelay from the crystal structure of the C-terminal HPt domain of ArcB. Cell (1997) 1.42

Demonstration of R factors in Bordetella bronchiseptica isolated from pigs. Antimicrob Agents Chemother (1973) 1.41

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol (1994) 1.41

Intracortical inhibition of the motor cortex is normal in chorea. J Neurol Neurosurg Psychiatry (1999) 1.41

Identification of novel VirR/VirS-regulated genes in Clostridium perfringens. Mol Microbiol (2000) 1.41

CSF tau protein: a new prognostic marker for Guillain-Barré syndrome. Neurology (2006) 1.40

Swelling-induced, CFTR-independent ATP release from a human epithelial cell line: lack of correlation with volume-sensitive cl(-) channels. J Gen Physiol (1999) 1.40

Cloning and sequencing of a phospholipase C gene of Clostridium perfringens. Biochem Biophys Res Commun (1989) 1.40

The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol Cell (1999) 1.40

Amyotrophic lateral sclerosis: electrophoretic study of amorphous material of skin. J Neurol Sci (1989) 1.39

Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet (1991) 1.39

Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum Mol Genet (2000) 1.38